Birmingham, West Midlands -- (SBWIRE) -- 12/03/2013 -- Value Penny Stocks issues special report on Geron Corporation (NASDAQ:GERN), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), TiVo Inc. (NASDAQ:TIVO), Array Biopharma Inc (NASDAQ:ARRY).
Geron Corporation (NASDAQ:GERN) opened its last trade at the price of $5.37. Its closing price was $5.73 after gaining 6.70% for the day. The company traded with the total volume of 4.11 million shares, while its average trading volume remained 5.91 million shares. The beta of this stock stands at 1.24. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
For How Long GERN will Fight for Profitability? Read This Trend Analysis report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) percentage change surged 2.15% to close at $6.66 with the total traded volume of 3.96 million shares, along with average volume of 5.74 million shares. The 52 week range of the stock remained $6.50 - $6.67, while its day lowest price was $6.50. The share price hit the day highest price of $6.67. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long ARNA’s Gloss will Attract Investors? Find out via this report
TiVo Inc. (NASDAQ:TIVO) traded on volume of 3.88 million shares in the last session against average volume of 3.06 million shares. The company started its trading session with the price of $12.77 and closed at $12.77 by scoring -0.47%. TiVo Inc., together with its subsidiaries, provides software and service technology that enables the distribution of video content on digital video recorders (DVRs), non-DVR set-top boxes (STB), computers, smartphones, and tablets in the United States and internationally.
Why Should Investors Buy TIVO After the Recent Fall? Just Go Here and Find Out
Array Biopharma Inc (NASDAQ:ARRY) started its last trading session with the price of $.64 and closed at $5.80 by scoring 1.40%. The stock traded with total volume of 3.87 million shares, while the average trading volume remained 1.68 million shares. The beta value of this stock stands at 1.67. Day range for the stock was $5.57 - $5.83. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
Why Should Investors Buy ARRY After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)